Chia CW, Carlson OD, Kim W, Shin YK, Charles CP, Kim HS, Melvin DL, Egan JM
Occurrence of serious adverse events in individuals with type 2 diabetes receiving liraglutide or semaglutide: results from the LEADER and SUSTAIN 6 trials. Diabetes, Obesity & Metabolism
The company's twenty-plus years of experience in pharmaceutical ingredient manufacturing and comprehensive certification portfolio including cGMP, Kosher, Halal, BRC, and organic certifications demonstrate commitment to quality standards that extend through proper storage guidance and technical support
Buyer is responsible for inspecting and refrigerating or freezing the Product promptly upon receipt in accordance with the storage instructions on the Certificate of Analysis